I apologize to regular readers who may be growing weary of my continually posting examples of awful reporting in the therapeutic cloning debate. But this “bias by omission” as I call it, is truly ...

A Nov. 5 Business article mischaracterized the actions of a Food and Drug Administration advisory committee studying animal cloning as an agricultural tool. The reported sentiment of the committee -- ...